Overview
Ryo Amagai practices practicing medicine in Japan.
Mr. Amagai is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), Angiosarcoma, T-Cell Lymphoma, and Melanoma.
He is actively involved in clinical research, co-authoring 58 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ryo Amagai
Is Ryo Amagai a top-rated expert for Cutaneous T-Cell Lymphoma (CTCL)?
MediFind is an objective health platform that identifies experts based on real-world data. Ryo Amagai is classified as an Advanced expert for Cutaneous T-Cell Lymphoma (CTCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ryo Amagai participate in research or clinical trials?
Yes. Ryo Amagai has published 58 articles and abstracts on conditions like Cutaneous T-Cell Lymphoma (CTCL). You can view a list of Ryo Amagai's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AngiosarcomaMr. Amagai isAdvanced. Learn about Angiosarcoma.
- Cutaneous T-Cell Lymphoma (CTCL)Mr. Amagai isAdvanced. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- MelanomaMr. Amagai isAdvanced. Learn about Melanoma.
- Mycosis FungoidesMr. Amagai isAdvanced. Learn about Mycosis Fungoides.
- T-Cell LymphomaMr. Amagai isAdvanced. Learn about T-Cell Lymphoma.
- Experienced
- Adult Soft Tissue SarcomaMr. Amagai isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Anaplastic Large Cell LymphomaMr. Amagai isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Angiosarcoma of the ScalpMr. Amagai isExperienced. Learn about Angiosarcoma of the Scalp.
- Epidermoid CystMr. Amagai isExperienced. Learn about Epidermoid Cyst.
- Erythema NodosumMr. Amagai isExperienced. Learn about Erythema Nodosum.
- Extramammary Paget DiseaseMr. Amagai isExperienced. Learn about Extramammary Paget Disease.
- FibrosarcomaMr. Amagai isExperienced. Learn about Fibrosarcoma.
- Hidradenitis SuppurativaMr. Amagai isExperienced. Learn about Hidradenitis Suppurativa.
- Lung MetastasesMr. Amagai isExperienced. Learn about Lung Metastases.
- Lymphomatoid PapulosisMr. Amagai isExperienced. Learn about Lymphomatoid Papulosis.
- Muir-Torre SyndromeMr. Amagai isExperienced. Learn about Muir-Torre Syndrome.
- Neurofibromatosis Type 2 (NF2)Mr. Amagai isExperienced. Learn about Neurofibromatosis Type 2 (NF2).
- Non-Hodgkin LymphomaMr. Amagai isExperienced. Learn about Non-Hodgkin Lymphoma.
- UveitisMr. Amagai isExperienced. Learn about Uveitis.
- Vogt-Koyanagi-Harada DiseaseMr. Amagai isExperienced. Learn about Vogt-Koyanagi-Harada Disease.
- Wilms TumorMr. Amagai isExperienced. Learn about Wilms Tumor.